Investing in vaccine stocks today is different than it was a year ago.
News & Analysis: Gritstone bio, Inc.
The coronavirus presents one big risk in the future. This vaccine maker is tackling it.
Gritstone's COVID-19 vaccine may have a critical role to play in halting the ongoing pandemic.
The pricing of a secondary stock offering is taking a toll on the biotech stock.
With a new CEO from Roche on the way, these companies' odds of being acquired just rose a notch.